Aerosolized recombinant alpha1-antitrypsin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aerosolized recombinant alpha1-antitrypsin, covering 2021-05-05 to 2021-05-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency [Phase 1, Phase 2]